Retinal Ganglion Cell Plasticity in Glaucoma

青光眼视网膜神经节细胞可塑性

基本信息

项目摘要

DESCRIPTION (provided by applicant): Retinal ganglion cell (RGC) death is the primary cause of irreversible blindness in Open Angle Glaucoma (OAG) and most optic neuropathies. The goal of this project is to prevent blindness in these diseases by obtaining the information needed to understand the etiology of RGC vulnerability, and use this understanding to develop approaches that prevent cell death. Our objective is determining RGC susceptibility to stressors such as IOP elevation, metabolic load, and neurotrophic factor (NT) deficiency in mouse models of glaucoma and optic neuropathy during the stage of progressive RGC dysfunction preceding death (critical period). Our central hypothesis is that RGC death is the result of failure of autoregulatory/adaptive processes that can no longer sustain normal RGC homeostasis, resulting in loss of RGC electrical responsiveness. During the critical period, RGC responsiveness is modifiable (plastic) upon stressors such as IOP, metabolic demand and NT support, thus providing a rationale and a target for therapeutic intervention. Using innovative methods, we will acutely modulate the levels of these stressors and simultaneously assess modifiability of RGC electrical responsiveness over time using pattern electroretinogram (PERG) and visual evoked potential (VEP). We will also use state-of-the-art optical coherence tomography (OCT) to serially monitor thickness of inner retinal layers, as well as retinal immunohistochemistry at endpoint. We will attain our goal and objective by accomplishing the following aims: 1) Test the hypothesis that RGC plasticity occurs in a specific time window in mouse models of glaucoma and optic neuropathy. Models will be the Myoc transgenic mouse of glaucoma, the ND4 transgenic mouse of multiple sclerosis, and the MOG-specific TCR transgenic mouse of optic neuritis. Controls will be corresponding non-pathological congenic mice. We will non-invasively alter either IOP with changes of body posture, or the metabolic demand with flickering light, and will measure corresponding changes of the PERG/VEP signal that precede loss of OCT signal; 2) Test the hypothesis that RGC plasticity is inducible in mouse models of chronic NT deficiency. We will perform unilateral lesions of the superior colliculus (SC) in C57BL/6J and DBA/2J mice and will quantify changes of the PERG and OCT signal in each eye. We will also induce IOP and metabolic stress in SC-lesioned mice to quantify acquired susceptibility of the PERG signal. Successful completion of our research will establish a new conceptual model of RGC susceptibility, and will improve our technical capability of detecting diseases' onset, monitoring their progression and the effect of treatment, eventually changing clinical practice. This will represent a significant advancement in the field and will be influential on future research on glaucoma and other neurodegenerative diseases involving RGC. PUBLIC HEALTH RELEVANCE: Glaucoma and optic neuropathies are leading causes of irreversible blindness, whose common cause is retinal ganglion cell (RGC) death. In this project we investigate the hypothesis that RGC dysfunction and demise is initiated by failure of autoregulatory processes that can no longer sustain normal homeostasis, resulting in progressive loss of pattern electroretinogram and susceptibility to stressors such as IOP elevation, increased metabolic demand, and neurotrophic factors deficiency. Understanding the etiology of RGC vulnerability is a necessary step to develop therapeutic approaches that reduce or eliminate its effects on cell death.
描述(由申请人提供):视网膜神经节细胞(RGC)死亡是开角型青光眼(OAG)和大多数视神经病变不可逆失明的主要原因。该项目的目标是通过获取了解RGC易感性的病因所需的信息来预防这些疾病的失明,并利用这种了解来开发预防细胞死亡的方法。我们的目的是确定在死亡前(关键时期)进行性RGC功能障碍阶段的青光眼和视神经病变小鼠模型中RGC对压力源的易感性,如IOP升高、代谢负荷和神经营养因子(NT)缺乏。我们的中心假设是,研资局死亡是由于自我调节/适应过程失败,无法维持正常的研资局稳态,导致研资局电反应丧失。在关键时期,RGC的反应是可改变的(可塑性的),如IOP、代谢需求和NT支持等应激源,从而为治疗干预提供了理论基础和目标。使用创新的方法,我们将急性调节这些应激源的水平,同时使用模式视网膜电图(PERG)和视觉诱发电位(VEP)评估RGC电反应随时间的可变性。我们还将使用最先进的光学相干断层扫描(OCT)来连续监测视网膜内层的厚度,以及终点的视网膜免疫组织化学。我们将通过实现以下目标来实现我们的目标:1)在青光眼和视神经病变小鼠模型中验证RGC可塑性在特定时间窗内发生的假设。模型为青光眼Myoc转基因小鼠,多发性硬化症ND4转基因小鼠,视神经炎mog特异性TCR转基因小鼠。对照为相应的非病理性基因小鼠。我们将通过身体姿势的变化无创地改变眼压,或通过闪烁的光改变代谢需求,并测量OCT信号丢失之前PERG/VEP信号的相应变化;2)验证RGC可塑性在慢性NT缺乏小鼠模型中可诱导的假设。我们将对C57BL/6J和DBA/2J小鼠进行单侧上丘(SC)病变,并量化每只眼睛PERG和OCT信号的变化。我们还将在sc损伤小鼠中诱导IOP和代谢应激,以量化PERG信号的获得性敏感性。我们的研究的成功完成将建立一个新的RGC易感性概念模型,并将提高我们检测疾病发病、监测疾病进展和治疗效果的技术能力,最终改变临床实践。这将代表该领域的重大进展,并将对未来涉及RGC的青光眼和其他神经退行性疾病的研究产生影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VITTORIO PORCIATTI其他文献

VITTORIO PORCIATTI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VITTORIO PORCIATTI', 18)}}的其他基金

RETINAL GANGLION CELL PLASTICITY IN GLAUCOMA
青光眼视网膜神经节细胞的可塑性
  • 批准号:
    7508411
  • 财政年份:
    2009
  • 资助金额:
    $ 33.85万
  • 项目类别:
RETINAL GANGLION CELL PLASTICITY IN GLAUCOMA
青光眼视网膜神经节细胞的可塑性
  • 批准号:
    7895585
  • 财政年份:
    2009
  • 资助金额:
    $ 33.85万
  • 项目类别:
Retinal Ganglion Cell Plasticity in Glaucoma
青光眼视网膜神经节细胞可塑性
  • 批准号:
    8893991
  • 财政年份:
    2009
  • 资助金额:
    $ 33.85万
  • 项目类别:
Retinal Ganglion Cell Plasticity in Glaucoma
青光眼视网膜神经节细胞可塑性
  • 批准号:
    8536296
  • 财政年份:
    2009
  • 资助金额:
    $ 33.85万
  • 项目类别:
LIFE AND DEATH OF RETINAL GANGLION CELLS
视网膜神经节细胞的生与死
  • 批准号:
    7057225
  • 财政年份:
    2005
  • 资助金额:
    $ 33.85万
  • 项目类别:
LIFE AND DEATH OF RETINAL GANGLION CELLS
视网膜神经节细胞的生与死
  • 批准号:
    6846493
  • 财政年份:
    2005
  • 资助金额:
    $ 33.85万
  • 项目类别:
LIFE AND DEATH OF RETINAL GANGLION CELLS
视网膜神经节细胞的生与死
  • 批准号:
    7226618
  • 财政年份:
    2005
  • 资助金额:
    $ 33.85万
  • 项目类别:
REVERSIBLE GANGLION CELL DYSFUNCTION IN GLAUCOMA
青光眼可逆性神经节细胞功能障碍
  • 批准号:
    7995181
  • 财政年份:
    2004
  • 资助金额:
    $ 33.85万
  • 项目类别:
Miami Center for Vision Research
迈阿密视觉研究中心
  • 批准号:
    7217866
  • 财政年份:
    2004
  • 资助金额:
    $ 33.85万
  • 项目类别:
Reversible Ganglion Cell Dysfunction in Glaucoma
青光眼可逆性神经节细胞功能障碍
  • 批准号:
    7111872
  • 财政年份:
    2004
  • 资助金额:
    $ 33.85万
  • 项目类别:

相似海外基金

MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
  • 批准号:
    10490338
  • 财政年份:
    2021
  • 资助金额:
    $ 33.85万
  • 项目类别:
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
  • 批准号:
    10353104
  • 财政年份:
    2021
  • 资助金额:
    $ 33.85万
  • 项目类别:
Investigating pollution dynamics of swimming pool waters by means of chemical and biological markers
利用化学和生物标记物研究游泳池水体的污染动态
  • 批准号:
    21K04320
  • 财政年份:
    2021
  • 资助金额:
    $ 33.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
  • 批准号:
    10688286
  • 财政年份:
    2021
  • 资助金额:
    $ 33.85万
  • 项目类别:
Novel biological markers for immunotherapy and comprehensive genetic analysis in thymic carcinoma
用于胸腺癌免疫治疗和综合遗传分析的新型生物标志物
  • 批准号:
    20K17755
  • 财政年份:
    2020
  • 资助金额:
    $ 33.85万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
  • 批准号:
    10578649
  • 财政年份:
    2019
  • 资助金额:
    $ 33.85万
  • 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
  • 批准号:
    10295141
  • 财政年份:
    2019
  • 资助金额:
    $ 33.85万
  • 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
  • 批准号:
    10041708
  • 财政年份:
    2019
  • 资助金额:
    $ 33.85万
  • 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
  • 批准号:
    9776149
  • 财政年份:
    2019
  • 资助金额:
    $ 33.85万
  • 项目类别:
Combining biological and non-biological markers to develop a model predictive of treatment response for individuals with depression
结合生物和非生物标志物来开发预测抑郁症患者治疗反应的模型
  • 批准号:
    2063934
  • 财政年份:
    2018
  • 资助金额:
    $ 33.85万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了